LifeLines
Interviews, insights, and innovation leading the way for life science.
video
Your Story is Our Story
Decades of research have revealed a critical insight: Immune system dysfunction in autoimmune diseases isn’t just about overactivity—it’s about imbalance. Sonoma Biotherapeutics is leading the way in restoring that balance through cell therapy. With a deep commitment to scientific innovation and collaboration, Sonoma is working to bring this new class of medicine to patients, overcoming the complexities of scaling cell therapies and ushering in a new chapter in autoimmune treatment.
Join us for our video series, Your Story is Our Story, featuring groundbreaking achievements and exclusive behind-the-scenes looks at pioneering companies shaping the future of life science in California.
Interviews
Member Spotlight


November 7, 2024
Sapient Bioanalytics is Using a Multi-Omics Approach That Looks Beyond the Genome in Drug Discovery
Member Spotlight


October 10, 2024
MeCo Diagnostics’ Predictive Biomarker Test Could Connect Breast Cancer Patients to New Therapies
Insights
Capital Development


January 23, 2025
Our Top Takeaways from JPM 2025: Resurgent Deals and Evolving Healthcare Policies
Members in Action


October 10, 2024
Guidelines for a Successful Laboratory Relocation: Why Timing, Planning and Communication Are Essential
Members in Action


August 15, 2024
Accelerating Targeted Protein Degradation Research with AI and Machine Learning
Policy Perspective


June 13, 2024
A Mid-Year Recap on Policies Shaping the Life Science Industry
Innovation
Trending Topic

